Eptinezumab for Migraine Prevention

Spotlight on Migraine®

Vyepti or Eptinezumab is the first and only FDA approved intravenous treatment for migraine prevention. Neurologist, Dr. Stewart Tepper describes how eptinezumab works and who could benefit from it the most.

*The contents of this podcast are intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. AMD and the speaker do not recommend or endorse any specific course of treatment, products, procedures, opinions, or other information that may be mentioned. Reliance on any information provided by this content is solely at your own risk.